Microenvironment and HIV-related lymphomagenesis

Seminars in Cancer Biology

Volumn 34, Issue , 2015, Pages 52-57

  Pantanowitz, Liron ^a   Carbone, Antonino ^b   Dolcetti, Riccardo ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

AIDS; EBV; HHV8; HIV; Lymphoma; Microenvironment

Indexed keywords

BURKITT LYMPHOMA; CARCINOGENESIS; CLASSICAL HODGKIN LYMPHOMA; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOMAGENESIS; MARGINAL ZONE LYMPHOMA; NONHUMAN; PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; PLASMABLASTIC LYMPHOMA; POLYMORPHIC B CELL LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; HERPES VIRUS INFECTION; LYMPHOMA, AIDS-RELATED; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; TUMOR MICROENVIRONMENT;

EID: 84942294134     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2015.06.002     Document Type: Review

References (44)

1. Raphael M., Said J., Borisch B., Cesarman E., Harris N.L. Lymphomas associated with HIV infection. WHO Classification of Tumours of Haematopoeitic and Lymphoid Tissues 2008, 340-342. IARC Press, Lyon. fourth ed. S.H. Swerdlow, E. Campo, N.L. Harries, A. et (Eds.).
2. Dunleavy K., Bollard C.M. Scouting out the neighborhood in AIDS-related lymphoma. Blood 2013, 122:306-307.
3. Teruya-Feldstein J. Diffuse large B-cell lymphomas with plasmablastic differentiation. Curr. Oncol. Rep. 2005, 7:357-363.
4. Aboulafia D.M., Pantanowitz L., Dezube B.J. AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART. AIDS Read 2004, 14:605-617.
5. Straus D.J., Huang J., Testa M.A., Levine A.M., Kaplan L.D. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142-low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J. Clin. Oncol. 1998, 16:3601-3606.
6. Jaffar S.A., Pihan G., Dezube B.J., Pantanowitz L. Differentiating HIV-associated lymphomas that exhibit plasmacellular differentiation. HIV AIDS 2005, 4:43-49. (Review).
7. Carbone A., Vaccher E., Gloghini A., Pantanowitz L., Abayomi A., de P.P., et al. Diagnosis and management of lymphomas and other cancers in HIV-infected patients. Nat. Rev. Clin. Oncol. 2014, 11:223-238.
8. Frisch M., Biggar R.J., Engels E.A., Goedert J.J. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001, 285:1736-1745.
9. Herida M., Mary-Krause M., Kaphan R., Cadranel J., Poizot-Martin I., Rabaud C., et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J. Clin. Oncol. 2003, 21:3447-3453.
10. Clifford G.M., Rickenbach M., Lise M., Dal M.L., Battegay M., Bohlius J., et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood 2009, 113:5737-5742.
11. Thompson L.D., Fisher S.I., Chu W.S., Nelson A., Abbondanzo S.L. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. Am. J. Clin. Pathol. 2004, 121:727-738.
12. Herreros B., Sanchez-Aguilera A., Piris M.A. Lymphoma microenvironment: culprit or innocent?. Leukemia 2008, 22:49-58.
13. Burger J.A., Ghia P., Rosenwald A., Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009, 114:3367-3375.
14. Liapis K., Clear A., Owen A., Coutinho R., Greaves P., Lee A.M., et al. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. Blood 2013, 122:424-433.
15. Caccuri F., Giagulli C., Bugatti A., Benetti A., Alessandri G., Ribatti D., et al. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:14580-14585.
16. Huysentruyt L.C., McGrath M.S. The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma. J. Leukocyte Biol. 2010, 87:627-632.
17. Hartmann S., Jakobus C., Rengstl B., Doring C., Newrzela S., Brodt H.R., et al. Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma. Mod. Pathol. 2013, 26:648-657.
18. Carbone A., Cesarman E., Spina M., Gloghini A., Schulz T.F. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009, 113:1213-1224.
19. Carbone A., Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br. J. Haematol. 2005, 130:662-670.
20. Epeldegui M., Vendrame E., Martinez-Maza O. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma. Immunol. Res. 2010, 48:72-83.
21. Rahn H., Lewis N., Bryan L., Petrich A., Vladislav A., Chadburn A. Systemic HIV associated lymphomas-biologic differences as related to combined anti-retroviral therapy (cART). Mod. Pathol. 2014, 27:372-A. (Abstract).
22. Vendrame E., Hussain S.K., Breen E.C., Magpantay L.I., Widney D.P., Jacobson L.P., et al. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk. Cancer Epidemiol. Biomarkers Prev. 2014, 23:343-349.
23. Martin G., Tremblay M.J. HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. Clin. Immunol. 2004, 111:275-285.
24. Martin G., Roy J., Barat C., Ouellet M., Gilbert C., Tremblay M.J. Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells. J. Virol. 2007, 81:5872-5881.
25. Imbeault M., Ouellet M., Giguere K., Bertin J., Belanger D., Martin G., et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J. Virol. 2011, 85:2189-2200.
26. Gu X., Shivarov V., Strout M.P. The role of activation-induced cytidine deaminase in lymphomagenesis. Curr. Opin. Hematol. 2012, 19:292-298.
27. Robbiani D.F., Bunting S., Feldhahn N., Bothmer A., Camps J., Deroubaix S., et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 2009, 36:631-641.
28. Curreli S., Krishnan S., Reitz M., Lunardi-Iskandar Y., Lafferty M.K., Garzino-Demo A., et al. B cell lymphoma in HIV transgenic mice. Retrovirology 2013, 10:92.
29. Kundu R.K., Sangiorgi F., Wu L.Y., Pattengale P.K., Hinton D.R., Gill P.S., et al. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood 1999, 94:275-282.
30. Lazzi S., Bellan C., De F.G., Cinti C., Ferrari F., Nyongo A., et al. Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis. Hum. Pathol. 2002, 33:723-731.
31. Scala G., Ruocco M.R., Ambrosino C., Mallardo M., Giordano V., Baldassarre F., et al. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 1994, 179:961-971.
32. Blazevic V., Heino M., Lagerstedt A., Ranki A., Krohn K.J. Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1996, 13:208-214.
33. Srivastava D.K., Tendler C.L., Milani D., English M.A., Licht J.D., Wilson S.H. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase. AIDS 2001, 15:433-440.
34. Rusnati M., Presta M. HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis 2002, 5:141-151.
35. Giagulli C., Marsico S., Magiera A.K., Bruno R., Caccuri F., Barone I., et al. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE 2011, 6:e17831.
36. Martorelli D., Muraro E., Mastorci K., Dal Col J., Faè D.A. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting. Int. J. Cancer 2015, (in press).
37. Giombini E., Dolcetti R., Caccuri F., Selleri M., Rozera G., Abbate I., et al. Detection of HIV-1matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. J. Acquir. Immune. Defic. Syndr. 2014, 66:332-339.
38. Shiramizu B., Hernider B., McGrath M. Identification of a common clonal HIV integration site in HIV-associated lymphomas. Cancer Res. 1994, 54:2069-2072.
39. McGrath M.D., Herndier B. Clonal HIV in the pathogenesis of AIDS-related lymphoma: sequential pathogenesis. Infectious Causes of Cancer: Targets for Intervention 2000, 231-242. Humana Press, Totowa, NJ. Goedert Editor (Ed.).
40. Pietersma F., Piriou E., Van Baarle D. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients. Leuk. Lymphoma 2008, 49:1028-1041.
41. Anthony I.C., Crawford D.H., Bell J.E. B lymphocites in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain 2003, 126:1058-1067.
42. Ometto L., Menin C., Masiero S., Bonaldi L., Del Mistro A., Cattelan A.M., et al. Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas. Blood 1997, 90:313-322.
43. Carbone A., Tirelli U., Gloghini A., Volpe R., Boiocchi M. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J. Clin. Oncol. 1993, 11:1674-1681.
44. Carbone A., Gloghini A. KSHV/HHV8-associated lymphomas. Br. J. Haematol. 2008, 140:13-24.